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Rhythms of the heart: The history 
of electrophysiology and its 
current status in South Africa
THE HISTORY 
OF ELECTRO-
PHYSIOLOGY
in1883 described the penetrating bundle of His, but did not 
prove that it conducted the electrical impulses from the atria to 
the ventricles.(2) 
During the 19th century, there were two theories as to the 
origin of cardiac rhythmicity. One view held that it was 
secondary to nervous stimulation via ganglia which had been 
observed on the heart. The other was that it was an intrinsic 
property of cardiac muscle. A key finding by Walter Gaskell in 
the 1880s was that an isolated strip of tortoise ventricular 
muscle, devoid of ganglia or nerves, continued to contract 
rhythmically at a rate similar to the intact heart, proving its 
intrinsic rhythmicity and he was responsible for elucidating the 
effects of the autonomic nervous system on the heart. Gaskell 
also followed up on the original experiments by Stannius in 
1852 and Luciani in 1873, in which a ligature around the AV 
groove resulted in AV block.(1,2,3)
It was Sunao Tawara from Japan, working in the laboratory of 
Ludwig Aschoff in Marburg, Germany, who discovered the AV 
node and delineated the continuity of the conduction system 
from the AV node, via the His bundle and bundle branches, 
to the ventricular myocardium. He published his findings in a 
beautifully illustrated monograph in 1906. There was now a 
sound anatomical and physiological basis for AV conduction.(4)
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INTRODUCTION
The field of cardiac electrophysiology (EP) has progressed from 
a niche activity practised by a few enthusiasts to one of the 
most popular branches of cardiology, thanks to the expanding 
therapeutic options offered by catheter ablation of arrhythmias 
and the increasing indications for cardiac implantable electronic 
devices (CIEDs). This review will look at the origins of the study 
of electrical phenomena in the heart and the growth of that 
knowledge. The status of EP in South Africa and sub-Saharan 
Africa will be discussed.
19TH CENTURY – ANATOMY AND 
PHYSIOLOGY
While there are references to arrhythmias in ancient times and 
Claudius Galen in the second century AD observed that a heart 
which had been excised and isolated, continued to beat on its 
own,(1) most of the important work on the basic anatomy and 
physiology of the electrical system of the heart took place in the 
19th and early 20th centuries. This work formed the foundation 
for understanding cardiac electrophysiology and arrhythmias.
In 1839 Jan Evangelista Purkinje described the fibres bearing his 
name from observations made in sheep hearts.(2) He did not, 
however, have any idea as to their true function. Wilhelm His Jr 
The foundations of cardiac electrophysiology were laid in 
the 19th and 20th century by the elucidation of the anat-
omy and physiology of the conduction system and cardiac 
muscle. The development of the ECG by Einthoven in the 
early 1900s has been the basis for its clinical application 
and remains the most important tool for diagnosis of 
arrhythmias. Invasive electrophysiological studies have 
refi ned and added to this understanding and led to the 
development of catheter ablation of cardiac arrhythmias. 
The invention of pacemakers and implantable cardio-
verter defi brillators (ICDs) has revolutionised the treat-
ment of patients with brady and tachyarrhythmias. 
Despite these advances, catheter ablation, pacemakers 
and ICDs are unavailable to the majority of patients living 
in sub-Saharan Africa. In South Africa, there is a paucity of 
electrophysiologists in the academic/public sector as 
almost all electrophysiologists serve patients with private 
health insurance.  SAHeart 2015;12:156-163
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FIGURE 2: Gaskell proved the myogenic origin of the 
cardiac impulse and investigated AV block and auto-
nomic influences on the heart. Mackenzie and Lewis 
clarified atrial fibrillation, together with other insights. 
Einthoven developed the ECG as a practical tool and 
Lewis established its place in clinical practice.
The picture was completed by the discovery of the sinus node 
in 1907 by Arthur Keith and Martin Flack.(1,5) This was subse-
quently confirmed to be the site of origin of the cardiac impulse 
by Thomas Lewis, using Einthoven’s electrocardiogram on the 
exposed heart.(2)
Karel Wenckebach in 1904 described the form of AV block 
that bears his name by means of pulse recordings, before the 
ECG became available. He was able to explain the original 
observations of this phenomenon made by Luciani in 1873.(6)
EARLY 20TH CENTURY
Development of the ECG
While Augustus Waller was the first to record a recognisable 
ECG in 1887,(7) the capillary electrometer which he used 
produced very low fidelity recordings. It was Willem Einthoven’s 
modification of the string galvanometer which enabled success-
ful recording of the heart’s electrical activity in the first few 
years of the 20th century.(8) His use of bipolar limb leads and 
the names he gave to the waves survive to this day. While 
Einthoven recognised the value of the ECG, it was Sir Thomas 
Lewis in London who pioneered its use as a clinical tool. 
William Hofmeyer (Don) Craib, a young South African on a 
Rockefeller fellowship to Harvard, challenged the prevailing 
negativity theory of Einthoven and Lewis. This described 
negativity as the major change at the surface of excited cardiac 
tissue. Craib conducted experiments which showed that this 
was not the case. He found that there were polyphasic swings 
in potential, from positive to negative and back again, during the 
passage of an excitation wave. He ascribed the differences 
between his findings and those of Lewis to his closer simula-
tion of the heart by surrounding the muscle in saline, versus 
Lewis’ thin film of saline.(9) He then proposed his doublet 
hypothesis in 1927, causing much controversy. He described an 
excitation wave as a succession of “doublets”. A “doublet” 
comprised of a simultaneous anode and cathode where current 
FIGURE 1: Purkinje, His and Tawara defined the AV 
conducting system. Keith, together with Flack, dis-
covered the sinus node.
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entered and exited a small fraction of muscle. The electrical 
activation proceeded in wave fronts from negative to positive. 
The idea was subsequently adopted and modified by Wilson as 
the dipole theory, which is still accepted today as the basis for 
the ECG.
The ECG has played a critical role in the understanding of 
cardiac arrhythmias and continues to be an indispensable tool 
in diagnosis and prognosis to this day. While ECG recording has 
been modified since Einthoven’s day to include the unipolar 
limb leads and chest leads by Wilson and recording techniques 
have been refined by new technology, the fundamentals of the 
ECG have not changed in more than 100 years. Because of this 
long history, interpretation has been progressively refined as 
new knowledge becomes available. As a result, it remains a 
uniquely valuable clinical tool in all aspects of cardiology, 
particularly in the diagnosis of cardiac arrhythmias. 
Atrial fibrillation (AF) was the first arrhythmia to attract major 
interest and research. The condition had long been known 
under a variety of names: “rebellious palpitations”, “delirium 
cordis” and “pulsus irregularis perpetuus”. James Mackenzie, a 
Scottish general practitioner from 1879 in Burnley, England, 
devoted much of his life to studying heart disease, and is 
considered one of the fathers of modern cardiology.(10) Using 
an ink-writing polygraph which he had helped develop, he 
recorded simultaneous jugular and carotid pulses. He described 
the a, c and v waves of the jugular pulse, and noted the 
disappearance of the a waves with the development of an 
irregular pulse in a patient with mitral stenosis. His interpreta-
tion of atrial standstill and “nodal rhythm” was corrected by 
Thomas Lewis in 1909 as a result of his recording of fibrillary 
waves on the ECG, using Einthoven’s string galvanometer. 
A little earlier, in 1909, Rothberger and Winterberg in Vienna 
had demonstrated fibrillation in experimental preparations. 
Einthoven had published an ECG in 1906 which clearly 
demonstrated AF, but he did not recognise its significance.
The concept of re-entry
In 1913 George Mines, a young man in his 20s, did experi-
ments on the electrical activity of circular strips of muscle from 
a turtle heart. He was able to demonstrate the phenomenon of 
re-entry and describe the conditions of refractoriness and 
conduction which made it possible.(11) His prescient comment: 
“I venture to suggest that a circulating excitation of this type 
may be responsible for some cases of paroxysmal tachycardia 
as observed clinically”, proved to be something of an under-
statement. Sadly, he died before the age of 30 and never lived 
to see this prediction come true.
MID-20TH CENTURY
Refi nement of the ECG
In the 1930s and 40s, the ECG expanded from Einthoven’s 
3 leads to the current 12 with the addition of the augmented 
unipolar limb leads and the unipolar chest leads, mainly as a 
result of work by Frank Wilson. This was not only crucial for 
improved diagnosis of myocardial infarction, but clarified the 
diagnosis of bundle branch block. 
In the last few decades, ECG signals have been recorded after 
digitising the analogue signals, resulting in greater clarity than 
recording with a hot stylus on heat-sensitive paper. It is now 
usual to record at least 3 leads simultaneously, as opposed 
to consecutive strips, which has been helpful in analysing 
arrhythmias.
Understanding arrhythmias
While many authors contributed to the understanding of 
arrhythmias by studying the ECG, the Chicago school of Louis 
Katz, Alfred Pick and Richard Langendorff was pre-eminent 
from the 1940s to the 1970s. Leo Schamroth in Johannesburg 
made huge contributions, not least by the publication of 
“An Introduction to Electrocardiography” in 1956 and “The 
Disorders of Cardiac Rhythm” in 1971. During this time, all 
the major concepts of impulse generation and conduction 
relevant to arrhythmias were deduced from standard surface 
ECG recordings. 
Laboratory work on isolated hearts and muscle strips delineated 
cardiac electrical activity at a cellular level and led to an under-
standing of membrane potentials and ion channels. The 
understanding of cardiac ion channels received a boost with the 
elucidation of the genetic defects responsible for the congenital 
long QT syndromes.
The demonstration by Dirk Durrer and his colleagues in 
Amsterdam (1967) that tachycardias in patients with Wolff-
Parkinson-White (WPW) syndrome could be initiated and 
terminated with single timed premature stimuli proved the 
mechanism to be re-entry.(12) A similar study reported by Hein 
Wellens and others from the same group indicated that scar-
related ventricular tachycardia was also due to re-entry.(13) 
These techniques became part of routine clinical EP studies 
(see below).
Defi brillation and cardioversion
The concept of electrical termination of ventricular fibrillation 
(VF) dates back to the 19th century, but the first practical steps 
toward this goal were taken by Hooker, Kouwenhoven and 
Langworthy in 1933,(14) Naum Gurvich in Moscow in 1939(15) 
(who also pioneered DC defibrillation and biphasic waveforms) 
and Claude Beck in Cleveland in 1947.(16) Beck is credited with 
the first successful defibrillation of a human being in 1947, 
when he resuscitated a young man undergoing surgery using a 
device that he had designed. Paul Zoll described the first cases 
of successful external defibrillation.(17) The subsequent develop-
ment of open heart surgery, cardiac catheterisation, inter-
ventional electrophysiology and percutaneous revascularisation 
THE HISTORY OF ELECTROPHYSIOLOGY
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would be unthinkable without the availability of electrical 
defibrillation.
Bernard Lown and Barouh Berkovits were responsible for the 
development of direct current defibrillation and synchronised 
cardioversion which remain standard to this day,(18) albeit with 
some modifications to improve the efficiency of the waveform.
Pacemakers
While a working pacemaker was constructed in the 1930s by 
Hyman, Paul Zoll is credited with developing the first effective 
transcutaneous pacemaker to treat Stokes-Adams syndrome 
due to complete heart block in 1952.(19) Sy Furman, while still 
a surgical resident at the Montefiore in New York in 1958, 
developed a transvenous pacing electrode which subsequently 
became the basis for modern permanent pacing systems.(20) He 
remained a leader in the field of cardiac pacing for the rest of 
his life.
Until the introduction of the implantable pacemaker, heart 
block was a lethal disease. One year survival was between 30 
and 50%.(21) The first pacemaker was implanted in 1958 into 
Arne Larsson, a Swedish engineer in his 40s with complete 
heart block and recurrent syncope. His wife was aware that 
Elmqvist and Senning at the Karolinska Institute in Stockholm 
had implanted experimental pacemakers in dogs. She managed 
to persuade Åke Senning to implant a unit in her husband, who 
survived another 43 years and many pacemaker replace-
ments.(22) Studies in the 1960s and early 70s, when only simple 
VOO and VVI units were implanted, showed survival rates of 
90% at one year and 5 year survivals of 60 to 80%, despite 
an average age of around 65 years at the time of implant.(23) 
Survival was similar to an age-matched cohort from the general 
population. Very few medical interventions can compare with 
pacing in respect of dramatic improvements in both quantity 
and quality of life.
The transistor was critical to the development of implantable 
pacemakers. Early units were powered by mercury cells which 
could not be sealed because they emitted hydrogen, resulting 
in poor reliability. The development of the lithium-iodide 
battery by Wilson Greatbatch in the early 1970s revolutionised 
pacemaker design and longevity.(24) Rapid technological 
advances over the past few decades have resulted in increased 
sophistication and reliability. Electrodes and leads, however, 
remain the weakest link which has led to the development of 
leadless pacemakers.(25)
His bundle recording and EP studies
There had been animal studies in which recordings had been 
made of His bundle activity, but it was the publication of the 
catheter technique for recording the His bundle in man, by 
Benjamin Scherlag and his colleagues in 1969,(26) that opened 
the way for clinical electrophysiological studies. It was initially 
widely applied to the study of conduction abnormalities, but 
soon began to incorporate timed premature atrial and ventri-
cular extrastimuli to induce and terminate tachycardias. Aside 
from diagnosis of tachyarrhythmias, it was widely used in the 
1970s and 80s for testing the efficacy of antiarrhythmic drugs. 
As catheter ablation of arrhythmias has developed, clinical EP 
studies have increasingly become therapeutic, rather than 
purely diagnostic.
Intracardiac recordings, stimulation studies and detailed map-
ping have validated most of the early concepts of arrhythmias 
deduced from the ECG and have vastly increased our under-
standing of clinical arrhythmias.
Antiarrhythmic drugs
It was recognised early in the 20th century that digitalis pre-
parations could slow the ventricular response in patients with 
atrial fibrillation. Quinidine was discovered in the 1920s and 
was found to be useful in converting AF to sinus rhythm and in 
maintaining that rhythm. Procainamide, lignocaine (lidocaine), 
disopyramide, mexiletine and many others were added during 
the 1960s and 70s. Vaughan Williams published a classification 
of antiarrhythmic drugs in 1970.(27) It was based on their effects 
on the action potential of isolated muscle strips and correlated 
with their effects on cardiac ion channels. The drugs, particularly 
Class I agents, were widely and enthusiastically used both for 
symptomatic tachyarrhythmias and prophylactically. The latter 
use arose from observations, made mainly by Bernard Lown, 
that ventricular fibrillation in patients with acute myocardial 
infarction was often triggered by premature ventricular 
complexes (PVCs) falling on the T-wave (“R on T” pheno-
menon), leading to the assumption that suppression of PVCs 
by lignocaine would prevent VF and improve survival. Lown’s 
group and others also noted a correlation between the 
frequency of PVCs in the post-infarction period and the 
incidence of sudden unexpected death.(28) This lead to the 
routine use of Class I antiarrhythmics (mainly quinidine in the 
USA) in survivors of myocardial infarction in whom PVCs were 
documented by Holter monitoring.
This practice continued until the Cardiac Arrhythmia Sup-
pression Trial (CAST)(29) was undertaken (against much opposi-
tion). The trial was stopped prematurely when it became clear 
that mortality in the active treatment group (using the Class IC 
agents flecainide, encainide and morizicine) was nearly 3 times 
that in the placebo group. Review of many smaller trials of 
Class I agents showed a similar trend.
Quinidine syncope had been noted in the 1920s and again in 
1950. The mechanism was shown to be torsades de pointes 
ventricular tachycardia due to prolongation of ventricular 
repolarisation.(30) Subsequently, a host of drugs has been shown 
to prolong the QT interval and promote torsades. The list 
includes not only Class I and III antiarrhythmics, but large 
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numbers of non-cardiac drugs – antipsychotics, antibiotics, 
antihistamines, bowel motility preparations, and many others. 
The list is available at https://www.crediblemeds.org/index.php/
login/dlcheck. This phenomenon of pro-arrhythmia, together 
with limited efficacy, seriously limits the usefulness of 
antiarrhythmic drugs.
Surgery
Recognition of the anatomical substrate for many arrhythmias 
led to the development of surgical techniques to remove, or 
ablate, the offending tissue. Nineteen sixty eight saw the first 
successful surgical division of an accessory AV connection 
responsible for reciprocating tachycardias in a patient with 
WPW syndrome.(31) This both proved the concept and 
provided a cure for the condition. Surgical removal of a left 
ventricular aneurysm was reported in the 1959 and was shown 
to prevent recurrent ventricular tachycardia.(32) Subsequent 
developments in this technique, using intra-operative mapping 
and selective removal of scar, improved the results considerably.
Surgical modification of the atria to cure AF has been practised 
since the 1980s. The most successful has been James Cox’s 
maze operation,(33) in which the atria are divided into corridors 
each too small to sustain the wandering re-entry circuits 
thought to perpetuate AF. The maze procedure has undergone 
many modifications and is still used in selected patients at the 
time of surgery for other conditions, especially mitral valve 
repair. While around twice as many patients are in sinus rhythm 
at one year after surgery following mitral surgery and ablation 
as with mitral surgery alone, no benefit in mortality or stroke 
has yet been demonstrated. In a recent trial, those having 
additional AF surgery were significantly more likely to need 
permanent pacing.(46)
LATE 20TH CENTURY
Catheter ablation
In 1982, Mel Scheinman and John Gallagher independently 
published reports of a technique to ablate the AV junction and 
produce complete heart block by means of a high energy 
discharge (up to 360J) delivered via the tip of an electrode 
catheter placed against the His bundle.(34,35) Heart block in-
duced in this manner, together with permanent pacing, was 
used mainly in patients in AF with ventricular rates uncontrolled 
by drugs. 
Fortunately, in 1987, the safer technique of catheter ablation 
using radio-frequency (RF) energy was introduced.(36) This has 
revolutionised the treatment of tachycardias. Together with 
advances in computerised mapping systems, RF has enabled 
FIGURE 3: An early Chardack Greatbatch pacemaker from the 1960s contrasted with a modern single chamber unit with 
bipolar tined transvenous electrode. 
Early pacemakers used mercury cells and discrete components enclosed in epoxy-resin to allow escape of hydrogen. Modern units with 
lithium batteries and sophisticated integrated circuits are hermetically sealed. The pacemaker on the right is an atrial triggered (VAT) device 
made by Elema-Schonander in the early 1970s. The atrial electrode was placed on the outside of the right atrium via a mediastinoscope. 
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the cure of more than 90% of patients with WPW syndrome 
and similar numbers with AV nodal re-entry tachycardia.(37) 
While procedure-related complications, such as tamponade 
and heart block still occur occasionally, the short term risks are 
generally worth it for the long term benefit, compared to the 
long term risks and poor efficacy of antiarrhythmic drugs.
In 1998, Michel Haissaguerre and his colleagues in Bordeaux 
observed high frequency discharges originating in the pul-
monary veins which appeared to be the triggers for atrial 
fibrillation.(38) He was able to ablate these foci with apparent 
cure of the AF. From this has developed the world-wide 
explosion in catheter ablation procedures for AF. Results in 
patients with paroxysmal AF and little or no associated struct-
ural heart disease are very good, although more than one 
procedure is often necessary to achieve the best result. The 
outcomes in those with long-standing “persistent” AF, par-
ticularly with older age and associated heart disease, are not as 
good. The potential complications and need for repeat 
procedures make it less attractive.(39)
Implantable cardioverter defi brillators
In 1967, a friend of Michel Mirowski died suddenly. This event 
spurred Mirowski, a cardiologist in Israel, to develop an 
implantable cardioverter defibrillator (ICD). He moved to 
Boston and, together with his colleague Morton Mower and 
engineers, developed an implantable device capable of auto-
matically delivering a shock of around 30J in response to a heart 
rate above a pre-set limit. This is sufficient to convert VF via an 
electrode in direct contact with the heart. The first human 
implant occurred in 1980.(40) Technological developments over 
the years have led to the incorporation of sophisticated detec-
tion algorithms, overdrive pacing to terminate ventricular 
tachycardia (VT), transvenous electrodes, smaller size, greater 
reliability and longer battery life. Trans-venous electrodes, how-
ever, are prone to failure and remain the weakest link in the 
ICD system. Subcutaneous ICDs have now been developed 
where the ICD lead is positioned outside of the heart, but have 
the disadvantage of not providing anti-tachycardia pacing of VT 
or back up bradycardia pacing.
The early units were implanted in patients resuscitated from 
cardiac arrest or with documented VT unresponsive to antia-
rrhythmic drugs. Major trials in the 1990s (MADIT) tested its 
use prophylactically in patients deemed at high risk for VF – 
those with severely depressed left ventricular function. They 
showed a modest but definite improvement in survival in 
comparison to conventional treatment and have become the 
standard of care in eligible patients.(41)
Cardiac resynchronisation therapy (CRT)
While not a therapy for arrhythmias, the concept and execu-
tion uses technology from the field. It has been shown that left 
bundle branch block (LBBB) with a QRS width of more than 
120ms may impair left ventricular function because of asyn-
chronous contraction. Correction of this abnormality by simul-
taneous pacing of the left and right ventricles has been shown 
to improve LV function in the majority and improves survival in 
patients with moderate and severe heart failure.(42)
EARLY 21ST CENTURY
Improving technology
The field of cardiac electrophysiology is advancing rapidly with 
improving technology. It is becoming increasingly popular, 
particularly with the rapid uptake of ablation for atrial fibrillation. 
In the USA, in 2010, there was one electrophysiologist for 
every 127 500 people. Most patients with WPW syndrome 
have had their accessory pathways ablated (the “Wolff” has 
become an endangered species!). The indications for, and 
practice of, AF ablation continues to expand. Opportunities 
for training abound in developed countries and resources 
allow for relatively unrestricted use of expensive treatments, 
such as ICDs.
FIGURE 4: Two early ICDs contrasted with a much 
smaller modern dual chamber ICD (below).
The patch electrode was sutured directly onto the pericardium 
over the apex, the second electrode being a transvenous coil in 
the superior vena cava. Modern systems use a single transvenous 
electrode, the shock being delivered between the electrode and 
the can of the ICD.
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World usage of pacemakers and ICDs
Every 4 years, Harry Mond of Australia coordinates the World 
Survey of Cardiac Pacing and Cardioverter-defibrillators, to 
which South Africa has contributed data since 1972. The most 
recent published survey was of the calendar year 2009.(43) 
In the USA, 767 pacemakers and 434 ICDs were implanted per 
million of the population in 2009. In Europe, pacemaker implant 
rates varied from 350 per million (Ireland and Serbia) to 927 in 
Germany, with most over 500. ICD implants ranged from 14 to 
290 per million (Germany), with most over 100.
Pacing and EP in South Africa and Africa
The picture in South Africa is very different. There are currently 
only 13 electrophysiologists (EPs) in South Africa accredited by 
CASSA (Cardiac Arrhythmia Society of South Africa), 12 of 
whom work predominantly or exclusively in private practice. 
The ratio of EPs to population is therefore around 1 for every 
4.5 million of the general population. There is, however, only 
one EP in the public/academic sector in South Africa.
The annual rate of new pacemaker implantations per million of 
the SA population has risen slowly from around 20 in the 1980s 
to 60 in 2009, with ICD implants of 6 per million – less than 
10% of that in most developed countries. This figure does not 
reveal the imbalance in distribution. There are no pacemaker 
implanters in 4 of South Africa’s 9 provinces. In 2005, the 
implant rate in those with health insurance was about 200/
million, as opposed to less than 10/million for those without. 
While some of this difference may be due to the different age 
distribution of the 2 groups, as there is a greater proportion of 
young people in the non-insured group, most is due to socio-
economic factors and limited access to tertiary health care. 
Since pacing for heart block is a lifesaving procedure, this 
imbalance is likely to translate into many deaths which could 
have been prevented. In addition, access to CRT and ICDs in 
the public sector is limited by financial constraints and lack of 
skilled personnel. 
The situation in the rest of sub-Saharan Africa is even worse. In 
a recent 2014 Pan African Society of Cardiology (PASCAR) 
survey,(44) only 7 other countries implant any pacemakers at 
all. The number of implants is low and there is a severe shortage 
of doctors skilled in permanent pacemaker implantation. Most 
pacemakers that are implanted are funded privately in 1 or 2 
specialised centres. 
What is to be done? The most pressing needs, in our view, are 
to improve access to pacing for indigent patients with heart 
block and to increase the number of pacemaker implanters. 
While we do not have any evidence that patients who are 
referred or find their way to a tertiary institution for pacing are 
denied the procedure, it is likely that many are going undetected 
at the level of primary health care or are not referred. Distance 
from a tertiary centre is likely to be a deterrent. Many primary 
care clinics do not have ECG machines. Efforts to increase 
awareness of arrhythmias in general and heart block, in partic-
ular, among staff in clinics and secondary hospitals need to be 
undertaken. CASSA has been active in this regard.
We need to get an estimate of the prevalence of conduction 
disease and serious arrhythmias in the population, particularly 
among older people. Surveys done more than 40 years ago 
suggested a lower prevalence among rural elderly blacks than 
among urban whites of a similar age,(45) but increasing urbanisa-
tion may have changed this.
PASCAR has formed a task force to address the problem of 
heart block and sudden death in Africa. Among other initiatives, 
it is arranging for health care professionals from other African 
countries to spend 6 months training in pacemaker implanta-
tion and follow up at Groote Schuur Hospital. It is also addres-
sing the issue of pacemaker and ICD re-use.
CONCLUSION
Cardiac electrophysiology made huge strides in the last century, 
building on the groundwork done in the 19th century. The 
invention of the ECG, its development and the continuous 
refinement of its interpretation has been pivotal in this process.
The implantable cardiac pacemaker was one of the greatest 
inventions of the 20th century. It converted a debilitating and 
lethal disease into a condition compatible with a normal pro-
ductive lifespan.
Catheter ablation, particularly in those with otherwise normal 
hearts, revolutionised the treatment of tachyarrhythmias. Its 
scope continues to expand to encompass complex rhythms, 
such as atrial fibrillation and ventricular tachycardias.
Improving technology contributes to shorter procedures and 
better outcomes.
Most important, however, is the availability of skilled clinicians 
and operators to make these advances available to patients. 
This is particularly true in sub-Saharan Africa. While South 
Africa is somewhat better served than the rest of the conti-
nent, we still fall woefully short of international standards of 
access. The huge discrepancy in access to lifesaving treatment 
mirrors the many other inequalities in our society.
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